Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/SLN/Operating income

Silence Therapeutics plc (SLN) Operating income 2022–2025

Silence Therapeutics plc (SLN) annual operating income history from SEC filings — each fiscal year as reported.

-$91.1MFY2025 · since FY2022: -$61.0M → -$91.1M
22232425
Fiscal yearValueYoY
FY2025-$91.1M-43.8%
FY2024-$63.3M+1.7%
FY2023-$64.4M-5.5%
FY2022-$61.0M—

Source: SEC XBRL filings · For reference only · Not investment advice

More SLN financial trends

SLN RevenueSLN Net incomeSLN Net marginSLN Gross profitSLN Gross marginSLN Operating marginSLN Operating cash flowSLN Free cash flowSLN Capital expendituresSLN Return on equitySLN Stock buybacksSLN Dividends paidSLN Total assetsSLN Total liabilitiesSLN Shareholders’ equitySLN overview →